The 20th edition of this annual training course, considered by many experts as one of the pillars of medical training in pharmacovigilance, focuses on how to use medical knowledge in the diagnosis and management of selected Adverse Drug Reactions (ADRs). ADRs of the main systems/organs will be presented and explained by experts in their medical domain in order to provide practical clues to understand and manage the serious reactions in clinical trials a well as in post authorisation.
A medical approach is needed for the identification, labelling and understanding of ADR mechanisms. It can also help assess the probability that a medicinal product may have played a role in the occurrence of an adverse event. This is particularly useful for the first 2 or 3 cases of serious reactions occurring during clinical trials when important decisions must be taken regarding a new drug under development.
The medical approach presented in this training course will take into consideration the conclusions of international or national consensus meetings on adverse drug reactions.
This course can be complemented by Drug-Induced Liver Injury (DILI): Diagnosis and Management, scheduled in the same venue directly after this course.
Who Should Attend
All healthcare professionals involved in the monitoring and assessment of adverse drug reactions occurred in drug development or after marketing; EU–QPPV, staff in charge of pharmacovigilance and /or drug safety investigators, staff in charge of clinical trials and safety studies, clinical research associates and monitors.
At the conclusion of this training course participants should be able to:
· Classify and define drug-induced affective symptoms, skin reactions, QT interval prolongation, blood disorders and acute renal failure.
· Describe their clinical patterns and appropriate investigations.
· Discuss the main non drug causes of the described disorders
Back-to-back Training Courses
Register online for Medical Approach in Diagnosis and Management of ADRs, ID#14540, and Diagnosis and Management of Drug Induced Liver Injury (DILI), ID#14544
AND SAVE UP TO EUR 490!
Hotel & Travel
DIA has blocked a limited number of rooms at the following hotel:
Hotel Novotel Paris Charenton
3-5 place des Marseillais
94227 CHARENTON LE PONT
at the rates of EUR 150.00 per room inclusive of breakfast and exclusive of VAT.
To make your reservation please use the hotel booking form.
Important: The room rate is available until 11 August 2014 or until the group block is sold-out, whichever comes first.
In case of cancellation: The room can be cancelled 43 hours prior arrival, after that the credit card will be charged for the 1st night.
The Hotel Novotel Paris Charenton is located 10 minutes from Gare de Lyon train station, the vibrant Bastille district & Bercy. The liberté metro station (line 8) opposite the hotel gives direct access to Paris's main attractions like Place de la Concorde, Eiffel Tower, Opéra, etc.